Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxin
Acute lymphoblastic leukemia (ALL) is the most common malignancy affecting children and a major cause of mortality from hematopoietic malignancies in adults. A substantial number of patients become drug resistant during chemotherapy, necessitating the development of alternative modes of treatment. r...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376225/ |